Welcome to vnonline.co.uk

vnonline.co.uk provides the veterinary nursing profession with the latest news and industry developments, as well as events, resources, learning materials and careers.

Our website is dedicated to veterinary nurses and we strive to provide a platform where you can voice and explore your interests.

Not a member yet? Sign up for free!

Register for free with vnonline.co.uk to gain unlimited access to news, resources, jobs and much more!



Click here to become a member







Log in to vnonline

Forgot your password?

Posted: 5th May 2020

New guidance to ensure availability of veterinary medicines
The guidance is aimed at companies that develop, manufacture and distribute veterinary medicines.
Q&A document addresses some of the constraints posed by the COVID-19 pandemic.

New guidance to ensure the availability of veterinary medicines during the COVID-19 pandemic have been produced by the European Commission, European Medicines Agency and the Coordination Group for Mutual Recognition and Decentralised Procedure-Veterinary.

The joint guidance, which comes in the form of a question and answer document, is aimed at companies that develop, manufacture and distribute veterinary medicines to address some of the constraints posed by the COVID-19 pandemic.

It sets out areas where regulatory rules for veterinary medicines should be applied with greater flexibility to mitigate the risk of supply disruptions caused by the pandemic. The areas covered include:
  • marketing authorisation procedures;
  • safety monitoring;
  • and inspections of manufacturing facilities and good manufacturing practice (GMP) for veterinary medicines.
The Q&A document will be continuously updated, and veterinary stakeholders are advised to check the EMA's website for regulatory information on the impact of the COVID-19 pandemic on veterinary medicines.




Become a member
or log in to add this story to your CPD history